Meet the Expert returns with its fifth episode on April 16, continuing the focus on acute migraine management, the CGRP pathway, emerging therapeutic options, and medication overuse headache through the lens of real-world clinical practice.

This distinctive case-based discussion forum brings together neurologists from across the country who will present challenging and thought-provoking migraine cases, each carefully reviewed by Dr. K. Ravishankar, one of India’s leading authorities in headache medicine.

Through the exploration of key diagnostic dilemmas and treatment decisions, the session will highlight practical management strategies, evolving clinical evidence, and the subtle nuances that influence expert migraine care. Designed to foster interactive learning and simplify complex clinical scenarios, this episode continues the Meet the Expert tradition of transforming everyday cases into valuable educational insights.

Meet The Expert: Episode 5

Senior Consultant Neurologist & Neurorehabilitation Specialist, Founder and Chairman of Magna Neurology and Solaceum Quick Relief, Hyderabad

RCP Migraine 2.0: Review of Current Practice in Migraine is a focused one-day virtual academic initiative dedicated to advancing contemporary migraine care through evidence-based discussions and real-world clinical insights. Scheduled for June 18, 2026, this high-impact program brings together leading experts to address critical gaps in acute migraine management and explore emerging therapeutic paradigms.

Under the scientific leadership of Dr. Debashish Chowdhury, the conference will center on the evolving role of novel therapies, with a special focus on CGRP antagonists such as rimegepant, and their application in routine clinical practice.

The agenda is designed to deliver clinically relevant, practice-oriented insights, covering:
- Limitations of Conventional Therapies – Understanding medication overuse, triptan resistance, and unmet patient needs
- Expanding Acute Treatment Options – Managing the triptan-insufficient response with newer agents like gepants
- Limitations of Conventional Therapies – Understanding medication overuse, triptan resistance, and unmet patient needs - Expanding Acute Treatment Options – Managing the triptan-insufficient response with newer agents like gepants
- Burden of Migraine & Emerging Evidence – Clinical and patient-centric rationale for next-generation therapies - CGRP antagonists in Prophylaxis – Addressing breakthrough attacks and redefining preventive strategies
- Complex Case Discussions – Real-world approaches in migraine prophylaxis with newer agents and status migrainosus with evolving emergency care protocols

Through expert-led keynotes and case-based discussions, RCP Migraine 2.0 aims to bridge the gap between clinical evidence and real-world practice, enabling clinicians to make informed, patient-centric treatment decisions.

Join us for an engaging academic experience and stay at the forefront of innovation in migraine management.

RCP Migraine 2.0

Dr. Debashish Chowdhury chairs this clinically focused case presentation. The session addresses the challenges of managing status migrainosus and reviews evolving emergency care protocols, emphasizing timely, evidence-based interventions in acute settings.

Dr. Sreekanth Vemula

3

521

13.5k

4.9

Upcoming Sessions

Sessions Taken

597

4.8